The pseudotumor cerebri syndrome

Neurologic Clinics

Volumn 32, Issue 2, 2014, Pages 363-396

  Friedman, Deborah I ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cerebrospinal fluid; Idiopathic intracranial hypertension; Papilledema; Pseudotumor cerebri

Indexed keywords

NORADRENALIN; SEROTONIN;

BRAIN EDEMA; BRAIN PSEUDOTUMOR; CEREBRAL SINUS THROMBOSIS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID PRESSURE; CEREBROSPINAL FLUID SHUNTING; CHRONIC DAILY HEADACHE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DRUG INDUCED HEADACHE; DRUSEN; ECHOGRAPHY; EYE MOVEMENT DISORDER; FLUORESCENCE ANGIOGRAPHY; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; INTRACRANIAL PRESSURE MONITORING; LATERAL SINUS THROMBOSIS; LUMBAR PUNCTURE; NAUSEA AND VOMITING; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEW DAILY PERSISTENT HEADACHE; OBESITY; OPHTHALMOPLEGIA; OPTIC DISK ANOMALY; OPTIC NERVE; OPTIC NERVE ATROPHY; PAPILLEDEMA; PERIMETRY; PHOTOPHOBIA; PRESSURE SENSATION; PRIMARY HEADACHE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SINUS VENOSUS; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; WEIGHT REDUCTION; ANIMAL; COMPLICATION; HEADACHE; PHYSIOLOGY; PSEUDOTUMOR CEREBRI; TREATMENT OUTCOME; VISION DISORDERS;

ANIMALS; HEADACHE; HUMANS; PAPILLEDEMA; PSEUDOTUMOR CEREBRI; TREATMENT OUTCOME; VISION DISORDERS; VISUAL ACUITY;

EID: 84898601548     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2014.01.001     Document Type: Review

References (256)

1. Friedman D.I., Liu G., Digre K.B. Diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013, 81(13):1159-1165.
2. Durcan F.J., Corbett J.J., Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988, 45:875-877.
3. Radhakrishanan K., Ahlskog J.E., Cross S.A., et al. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976-1990. Arch Neurol 1993, 50(1):78-80.
4. Kesler A., Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 2001, 21(1):12-14.
5. Radhakrishanan K., Sridharan R., Askhok P.P., et al. Pseudotumor cerebri: incidence and pattern in north-eastern Libya. Acta Neurol 1986, 25:117-124.
6. Jacobs DA, Corbett JJ, Balcer LJ. Annual incidence of idiopathic intracranial hypertension (IIH) in the Philadelphia area. Paper presented at: North American Neuro-Ophthalmology Society. Orlando, March 31, 2004.
7. Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci 1997, 24:219-221.
8. Scott I.U., Siatkowski R.M., Eneyni M., et al. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol 1997, 124(2):253-255.
9. Balcer L.J., Liu G.T., Forman S., et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999, 52:870-872.
10. Ko M.W., Liu G.T. Idiopathic intracranial hypertension. Horm Res Paediatr 2011, 74:381-389.
11. Bandyopadhyay S., Jacobson D.M. Clinical features of late life-onset pseudotumor cerebri fulfilling the Modified Dandy Criteria. J Neuroophthalmol 2002, 22:9-11.
12. Celebisoy N., Secil Y., Akyurekli O. Pseudotumor cerebri: etiological factors, presenting features and prognosis in the western part of Turkey. Acta Neurol Scand 2002, 106(6):367-370.
13. Wall M., George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991, 114:155-180.
14. Wall M, Kupersmith MJ, Kieburtz KD, et al.The Idiopathic Intracranial Hypertension Treatment Trial: Clinical Profile at Baseline. JAMA Neurology, in press.
15. Weig S.G. Asymptomatic idiopathic intracranial hypertension in young children. J Child Neurol 2002, 17(3):239-241.
16. Giuseffi V., Wall M., Spiegel P.Z., et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991, 41:239-244.
17. Round R., Keane J.R. The minor symptoms of increased intracranial pressure: 101 patients with benign intracranial hypertension. Neurology 1988, 38:1461-1464.
18. Ramadan N.M. Intracranial hypertension and migraine. Cephalalgia 1993, 13:210-211.
19. Friedman D.I., Rausch E.A. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002, 58:1551-1553.
20. Wang S.-J., Silberstein S.D., Patterson S., et al. Idiopathic intracranial hypertension without papilledema. A case-control study in a headache center. Neurology 1998, 51:245-249.
21. Sadun A.A., Currie J., Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol 1984, 16:489-494.
22. Corbett J.J., Savino P.J., Thompson H.S., et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982, 39:461-474.
23. Rush J.A. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980, 55:541-546.
24. Meador K.J., Swift T.R. Tinnitus from intracranial hypertension. Neurology 1984, 34:1258-1261.
25. Sismanis A. Otologic manifestations of benign intracranial hypertension syndrome: diagnosis and management. Laryngoscope 1987, 97:1-17.
26. Fishman R.A. Anatomical aspects of the cerebrospinal fluid. Cerebrospinal fluid in diseases of the nervous system 1992, 20-21. W.B. Sanders Co, Philadelphia. R. Fishman (Ed.).
27. Sismanis A., Hughes G.B., Abedi E., et al. Otologic symptoms and findings of the pseudotumor cerebri syndrome: a preliminary report. Otolaryngol Head Neck Surg 1985, 93:398-402.
28. Dorman P.J., Campbell M.J. Hearing loss as a false localising sign in raised intracranial pressure. J Neurol Neurosurg Psychiatry 1995, 58:516.
29. Bortoluzzi M., Di Lauro L., Marini G. Benign intracranial hypertension with spinal and radicular pain. J Neurosurg 1982, 57:833-836.
30. Selky A.K., Dobyns W.B., Yee R.D. Idiopathic intracranial hypertension and facial diplegia. Neurology 1994, 44:357.
31. Groves M.D., McCutcheon I.E., Ginsberg L.E., et al. Radicular pain can be a symptom of elevated intracranial pressure. Neurology 1999, 52:1093-1095.
32. Murray R.S., Tait V.F., Thompson J.A. Spinal and radicular pain in pseudotumor cerebri. Pediatr Neurol 1986, 2(2):106-107.
33. Kleinschmidt J.J., Digre K.B., Hanover R. Idiopathic intracranial hypertension. Relationship to depression, anxiety, and quality of life. Neurology 2000, 54:319-324.
34. Ross D.R., Coffey C.E., Massey E.W., et al. Depression and benign intracranial hypertension. Psychosomatics 1985, 26(5):387-393.
35. Kaplan C.P., Miner M.E., McGregor J.M. Pseudotumor cerebri: risk for cognitive impairment?. Brain Inj 1997, 11(4):293-303.
36. Wall M., White W.N. Asymmetric papilledema in idiopathic intracranial hypertension. Prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 1998, 39:132-142.
37. Spence J.D., Amacher A.L., Willis N.R. Benign intracranial hypertension without papilledema: role of 24-hour cerebrospinal fluid pressure monitoring in diagnosis and management. Neurosurgery 1980, 34:1509-1511.
38. Orcutt J.C., Page N.G., Sanders M.D. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology 1984, 91:1303-1312.
39. Wall M., George D. Visual loss in pseudotumor cerebri: incidence and defects related to visual field strategy. Arch Neurol 1987, 44:170-175.
40. Griebel S.R., Kosmorsky G.S. Choroidal folds associated with increased intracranial pressure. Am J Ophthalmol 2000, 129:513-516.
41. Frisén L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry 1982, 45:13-18.
42. Shuper A., Snir M., Barash D., et al. Ultrasonography of the optic nerves: clinical application in children with pseudotumor cerebri. J Pediatr 1997, 131:734-740.
43. Walsh T.J., Garden J.W., Gallangher B. Obliteration of retinal venous pulsations. Am J Ophthalmol 1969, 67:954-956.
44. Jacks A.S., Miller N.R. Spontaneous retinal venous pulsation: aetiology and significance. J Neurol Neurosurgy Psychiatry 2003, 74:7-9.
45. Verplanck M., Kaufman D.I., Parsons T., et al. Electrophysiology versus psychophysics in the detection of visual loss in pseudotumor cerebri. Neurology 1988, 38:1789-1792.
46. Wall M. Contrast sensitivity in pseudotumor cerebri. Ophthalmology 1986, 93:4-7.
47. Digre K.B., Nakamoto B.K., Warner J.E., et al. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache 2009, 49(2):185-193.
48. Ney J.J., Volpe N.J., Liu G.T., et al. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology 2009, 116(9):1801-1803.
49. Baker R.S., Buncic J.R. Vertical ocular motility disturbances in pseudotumor cerebri. J Clin Neuroophthalmol 1985, 5:41-44.
50. Frohman L.P., Kupersmith M.J. Reversible vertical ocular deviations associated with raised intracranial pressure. J Clin Neuroophthalmol 1985, 5:158-163.
51. Merikangas J.R. Skew deviation in pseudotumor cerebri. Ann Neurol 1978, 4:583.
52. Friedman D.I., Forman S., Levi L., et al. Unusual ocular motility disturbances with increased intracranial pressure. Neurology 1998, 50:1893-1896.
53. Snyder D.A., Frankel M. An unusual presentation of pseudotumor cerebri. Ann Ophthalmol 1979, 11:1823-1827.
54. Weisberg L.A. Computed tomography in benign intracranial hypertension. Neurology 1985, 35:1075-1078.
55. Jacobson D.M., Karanjia P.N., Olson K.A., et al. Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri. Neurology 1990, 40:1454-1455.
56. Maralani P.J., Hassanlou M., Torres C., et al. Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol 2012, 67:656-663.
57. Brodsky M.C., Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 1998, 105:1686-1693.
58. Zagardo M.T., Call W.S., Kelman S.E., et al. Reversible empty sella in idiopathic intracranial hypertension: an indicator of successful therapy?. AJNR Am J Neuroradiol 1996, 17:1953-1956.
59. Gass A., Barker G.J., Riordan-Eva P., et al. MRI of the optic nerve in benign intracranial hypertension. Neuroradiology 1996, 38:769-773.
60. Jinkins J.R., Zthale S., Xiong A., et al. MR of the optic papilla protrusion in patients with high intracranial pressure. AJNR Am J Neuroradiol 1996, 17:665-668.
61. Sinclair N., Asaad N., Johnston I. Pseudotumor cerebri occurring in association with the Chiari malformation. J Clin Neurosci 2002, 9(1):99-101.
62. Lam B.L., Schatz N.J., Glaser J.S., et al. Pseudotumor cerebri from cranial venous obstruction. Ophthalmology 1992, 99:706-712.
63. Cremer P.D., Thompson E.O., Johnston I.H., et al. Pseudotumor cerebri and cerebral venous hypertension. Neurology 1996, 47:1602.
64. King J.O., Mitchell P.J., Thomson K.R., et al. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology 1995, 45:2224-2228.
65. Farb R.I., Vanek I., Scott J.N., et al. Idiopathic intracranial hypertension. The prevalence and morphology of sinovenous stenosis. Neurology 2003, 60:1418-1424.
66. Baryshnik D.B., Farb R.I. Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure. Neurology 2004, 62:1445-1446.
67. Rohr A., Dörner L., Stingele R., et al. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2007, 28:656-659.
68. Avery R.A., Shah S.S., Licht D.J., et al. Reference range of cerebrospinal fluid opening pressure in children undergoing diagnostic lumbar puncture. N Engl J Med 2010, 363(9):891-893.
69. Ecker A. Irregular fluctuation of elevated cerebrospinal fluid pressure. AMA Arch Neurol Psychiatry 1955, 74:641-649.
70. Khandhar S., Friedman D.I. Cerebrospinal fluid measurements in patients experiencing severe, benign headaches. Headache 2003, 43(5):553-554.
71. Neville L., Egan R.A. Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can J Ophthalmol 2005, 40:775-777.
72. Bø S.H., Davidsen E.M., Benth J.Š. Cerebrospinal fluid opening pressure measurements in acute headache patients and in patients with either chronic or no pain. Acta Neurol Scand 2010, 122(Suppl 190):6-10.
73. Eidlitz-Markus T., Stiebel-Kalish H., Rubin Y., et al. CSF pressure measurement during anesthesia: an unreliable technique. Paediatr Anaesth 2005, 15(12):1078-1082.
74. Quinckne H. Uber meningitis serosa and verewandte zustande. Deutsche Zeitschrift für Nervenheilkunde 1897, 9:149-168. [in German].
75. Sahs A.L., Joynt R.J. Brain swelling of unknown cause. Neurology 1956, 6:791-803.
76. Wall M., Dollar J.D., Sadun A.A., et al. Idiopathic intracranial hypertension. Lack of histological evidence for cerebral edema. Arch Neurol 1995, 52:141-145.
77. Johnston I. The definition of a reduced CSF absorption syndrome: a reappraisal of benign intracranial pressure and related conditions. Med Hypotheses 1975, 1:10-14.
78. Johnston M., Zakharov A., Papaiconomou C., et al. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res 2004, 1(2):1-13.
79. Karahalios D.G., Rekate H.L., Khayata M.H., et al. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996, 46:198-202.
80. King J.O., Mitchell P.J., Thomson K.R., et al. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002, 58:26-30.
81. Biousse V., Ameri A., Bousser M.G. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999, 53:1537-1542.
82. Purvin V.A., Trobe J.D., Kosmorsky G. Neuro-ophthalmic features of cerebral venous obstruction. Arch Neurol 1995, 52:880-885.
83. Daif A., Awada A., Al-Rajeh S., et al. Cerebral venous thrombosis in adults: a study of 40 cases from Saudi Arabia. Stroke 1995, 26:1193-1195.
84. Quattrone A., Bono F., Oliveri R., et al. Cerebral venous thrombosis and isolated intracranial hypertension without papilledema in CDH. Neurology 2001, 57:31-36.
85. Corbett J.J., Digre K.B. Idiopathic intracranial hypertension. An answer to, "the chicken or the egg?". Neurology 2002, 58:5-6.
86. Sugarman H.J., DeMaria E.J., Felton W.L., et al. Increased aintra-abdominal pressure and cardiac filling pressure in obesity-associated pseudotumor cerebri. Neurology 1997, 49:507-511.
87. Digre K.B., Varner M.W., Corbett J.J. Pseudotumor cerebri and pregnancy. Neurology 1984, 34:721-729.
88. Lindvall M., Edvinsson L., Owman C. Reduced cerebrospinal fluid formation through cholinergic mechanisms. Neurosci Lett 1978, 9:77-82.
89. Lindvall M., Edvinsson L., Owman C. Effect of sympathomimetic drugs and corresponding receptor antagonists on the rate of cerebrospinal fluid production. Exp Neurol 1979, 64:132-145.
90. Lindvall M., Owman C. Autonomic nerves in the mammalian choroid plexus and their influence on the formation of cerebrospinal fluid. J Cereb Blood Flow Metab 1981, 1:245-266.
91. Nilsson C., Lindvall-Axelsson M., Owman C. Sympathetic nervous control of cerebrospinal fluid production from the choroid plexus. Science 1978, 201:176-178.
92. 1C receptor mRNA in the adult rat brain. FEBS Lett 1989, 247:453-462.
93. Pazos A., Baker R.S., Khorram D., et al. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol 1985, 106:539-546.
94. 1C receptors in the production of CSF from the choroid plexus. Neurotransmission and cerebrovascular function I 1989, 237-240. Elsevier, Amsterdam. J.M. Seylaz, E.T. MacKenzie (Eds.).
95. Friedman D.I., Ingram P., Rogers M.A. Low tyramine diet in the treatment of idiopathic intracranial hypertension. A pilot study. Neurology 1998, 50:A5.
96. Fishman R. Polar bear liver, vitamin A, aquaporins, and pseudotumor cerebri. Ann Neurol 2002, 52(5):531-533.
97. Wintour E.M. Water channels and urea transporters. Clin Exp Pharmacol Physiol 1997, 24(1):1-9.
98. King L.S., Agre P. Pathophysiology of the aquaporin water channels. Annu Rev Physiol 1996, 58:619-648.
99. Nielsen S., Nagelhus E.A., Amiry-Moghaddam M., et al. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997, 17(1):171-180.
100. Kerty E., Heuser K., Indahl U.G., et al. Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol 2013, 91(1):88-91.
101. Weber K.T. Aldersteronism revisited: perspectives on less well-recognized actions of aldosterone. J Lab Clin Med 2003, 142:71-82.
102. Kageyama Y., Suzuki H., Saruta T. Presence of aldeosterone-like immunoreactivity in cerebrospinal fluid in normotensive subjects. Acta Endocrinol (Copenh) 1992, 126:501-504.
103. Corbett J.J. The first Jacobson lecture: familial idiopathic intracranial hypertension. J Neuroophthalmol 2008, 24:337-347.
104. Wall M. Idiopathic intracranial hypertension and the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol 2013, 33(1):1-3.
105. Huff A.L., Hupp S.L., Rothrock J.F. Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension. Cephalalgia 1996, 16:451-452.
106. Marcelis J., Silberstein S.D. Idiopathic intracranial hypertension without papilledema. Arch Neurol 1991, 48:392-399.
107. Mathew N.T., Ravishankar K., Sanin L.C. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 1996, 46:1226-1230.
108. Green J.P., Newman N.J., Stowe Z.N., et al. "Normal pressure" pseudotumor cerebri. J Neuroophthalmol 1997, 17(4):279-290.
109. Barkana T, Levin N, Steiner I, et al. Pseudo-pseudotumor cerebri: Idiopathic intracranial hypertension with pleocytosis. Paper presented at: American Academy of Ophthalmology/Pan American Association of Ophthalmology. Orlando, October 20, 2002.
110. van Oosterhout W.P., Gagaouzova B.S., Terwindt G.M., et al. Transient intracranial pressure changes during a migraine attack. Cephalalgia 2013, 33(11):956.
111. Ireland B., Corbett J.J. The search for causes of idiopathic intracranial hypertension. Arch Neurol 1990, 47:315-320.
112. Wall M., Giuseffi V., Rojas P.B. Symptoms and disease associations in pseudotumor cerebri: a case-control study. Neurology 1989, 39:210.
113. Friedman D.I., Streeten D.H. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology 1998, 50:1099-1104.
114. Seckl J., Lightman S. Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1988, 51:1538-1541.
115. Sorenson P.S., Gjerris F., Hammer M. Cerebrospinal fluid vasopressin and increased intracranial pressure. Neurology 1982, 3:1255-1259.
116. Sorenson P.S., Hammer M., Gjerris F. Cerebrospinal fluid vasopressin in benign intracranial hypertension. Ann Neurol 1984, 15:435-440.
117. Thibonnier M.J., Marchetti J.P., Corvol P.J., et al. Abnormal regulation of antidiuretic hormone in idiopathic edema. Am J Med 1979, 67:67-73.
118. Sugerman H.J., Felton W.L., Salvant J.B., et al. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 1995, 45:1655-1659.
119. Kupersmith M.J., Gamell L., Turbin R., et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998, 50:1094-1098.
120. Johnson L.N., Krohel G.B., Madsen R.W., et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998, 105:2313-2317.
121. Tomsak R.L., Niffenegger A.S., Remler B.F. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuroophthalmol 1988, 18:93-98.
122. Lee A.G., Anderson R., Kardon R.H., et al. Presumed "sulfa allergy" in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality?. Am J Ophthalmol 2004, 138(1):114-118.
123. Corbett J.J., Thompson H.S. The rational management of idiopathic intracranial hypertension. Arch Neurol 1989, 46:1049-1051.
124. Liu G.T., Kay M.D., Bienfang D.C., et al. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol 1994, 117:352-357.
125. Liu G.T., Glaser J.S., Schatz N. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol 1994, 118:88-96.
126. Friedman D.I., Eller P.E. Topiramate for treatment of idiopathic intracranial hypertension. Headache 2003, 43(5):592.
127. Celebisoy N., Gokcay F., Sirin H., et al. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 2007, 116(5):322-327.
128. Godoy D.A., Rabinstein A.A., Biestro A., et al. Effects of indomethacin test on intracranial pressure and cerebral hemodynamics in patients with refractory intracranial hypertension: a feasibility study. Neurosurgery 2012, 71(2):245-257. [discussion: 257-8].
129. Wilkes B.N., Siatkowski R.M. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration. J Neuroophthalmol 2009, 29(4):281-283.
130. Ramsey C.N., Proctor B.L., Baker R.S., et al. Prevention of visual loss caused by shunt failure: a potential role for optic nerve sheath fenestration. Report of three cases. J Neurosurg 2006, 104(Suppl 2):149-151.
131. Kelman S.E., Sergott R.C., Cioffi G.A., et al. Modified optic nerve decompression in patients with functioning lumboperitoneal shunts and progressive visual loss. Ophthalmology 1991, 98:1449-1453.
132. Feldon S.E. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus 2007, 23(5):E6.
133. Keltner J.L. Optic nerve sheath decompression. How does it work? Has its time come?. Arch Ophthalmol 1988, 206:1365-1369.
134. Tsai J.C., Petrovich M.D., Sadun A.A. Histological and ultratructural examination of optic nerve sheath decompression. Br J Ophthalmol 1995, 79:182-185.
135. Hamed L.M., Tse D.T., Glaser J.S., et al. Neuroimaging of the optic nerve after fenestration for management of pseudotumor cerebri. Arch Ophthalmol 1992, 110:636-639.
136. Mittra R.A., Sergott R.C., Flaharty P.M., et al. Optic nerve decompression improves hemodynamic parameters in papilledema. Ophthalmology 1993, 100:987-997.
137. Lee S.Y., Shin D.H., Spoor T.C., et al. Bilateral retinal venous caliber decrease following unilateral optic nerve sheath decompression. Ophthalmic Surg 1995, 6:25-28.
138. Carter S.R., Seiff S.R. Macular changes in pseudotumor cerebri before and after optic nerve fenestration. Ophthalmology 1995, 102:937-941.
139. Ngyun R., Carta A., Geleris A., et al. Long-term effect of optic sheath decompression on intracranial pressure in pseudotumor cerebri. Invest Ophthalmol Vis Sci 1997, 38:S388.
140. Hansen H., Helmke K. Validation of optic nerve sheath response to changing cerebrospinal fluid pressure: ultrasound findings during intrathecal infusion. J Neurosurg 1997, 87(1):34-40.
141. Pearson P.A., Baker R.S., Khorram D., et al. Evaluation of optic nerve sheath fenestration in pseudotumor cerebri using automated perimetry. Ophthalmology 1991, 98:99-105.
142. Spoor T.C., Ramocki J.M., Madion M.P., et al. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression. Am J Ophthalmol 1991, 112:177-185.
143. Alsuhaibani A.H., Carter K.D., Nerad J.A., et al. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology 2011, 118(2):412-414.
144. Sergott R.C., Savino P.J., Bosley T.M. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 1988, 106:1384-1390.
145. Flynn W.J., Westfall C.T., Weisman J.S. Transient blindness after optic nerve sheath fenestration. Am J Ophthalmol 1994, 117:678-679.
146. Cornblath W.T., Miller N.R. Pseudotumor cerebri treated with lumbo-peritoneal shunt. Ann Neurol 1989, 26:183.
147. Johnston I., Besser M., Morgan M. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 1988, 69:195-202.
148. Sinclair A.J., Kuruvath S., Sen D., et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 2011, 31(16):1627-1633.
149. Eggenberger E.R., Miller N.R., Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996, 46:1524-1530.
150. Rosenberg M.L., Corbett J.J., Smith C., et al. Cerebrospinal diversion procedures for pseudotumor cerebri. Neurology 1993, 43:1071-1072.
151. Burgett R.A., Purvin V.A., Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997, 49:734-739.
152. Mauriello J.A., Shaderowfsky P., Gizzi M., et al. Management of visual loss after optic nerve sheath decompression in patients with pseudotumor cerebri. Ophthalmology 1995, 102:441-445.
153. Howard J., Appen R. Ventriculoperitoneal shunting for pseudotumor cerebri. Invest Ophthalmol Vis Sci 2002, 43. [E-abstract 2461].
154. Lee A.G. Visual loss as the manifesting symptoms of ventriculoperitoneal shunt malfunction. Am J Ophthalmol 1996, 122:127-129.
155. Liu G.T., Volpe N.J., Schatz N.J., et al. Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure. Am J Ophthalmol 1996, 122:129-131.
156. Alleyne C.H., Shutter L.A., Colohan A.R. Cranial migration of a lumboperitoneal shunt catheter. South Med J 1996, 89:634-646.
157. Miller N.R. Bilateral visual loss and simultagnosia after lumboperitoneal shunt for pseudotumor cerebri. J Neuroophthalmol 1997, 17:36-38.
158. Turkoglu E., Kazanci B., Karavelioglu E., et al. Intracerebral hematoma following lumboperitoneal shunt insertion: a rare case report. Turk Neurosurg 2011, 21(1):94-96.
159. Johnston I.H., Sheridan M.M. CSF shunting from the cisterna magna: a report of 16 cases. Br J Neurosurg 1993, 7:39-44.
160. Abu-Serieh B., Ghassempour K., Duprez T., et al. Stereotactic ventriculoperitoneal shunting for refractory idiopathic intracranial hypertension. Neurosurgery 2007, 60(6):1039-1043. [discussion: 1043-4].
161. Owler B.K., Parker G., Halmagyi G.M., et al. Pseudotumor cerebri syndrome: venous sinus obstruction and its treatment with stent placement. J Neurosurg 2003, 98:1045-1055.
162. Higgins J.N., Cousins C., Owler B.K., et al. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry 2003, 74:1662-1666.
163. Ahmed R., Wilkinson M.J., Parker G., et al. Management of idiopathic intracranial hypertension (IIH) with stenting of transverse sinus stenosis 2011, North American Neuro-Ophthalmology Society, Vancouver (Canada).
164. Arac A., Lee M., Steinberg G.K., et al. Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus 2009, 27(5):E14.
165. Donnet A., Metellus P., Levrier O., et al. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology 2008, 70(8):641-647.
166. Puffer R.C., Mustafa W., Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J Neurointerv Surg 2013, 5(5):483-486.
167. Friedman D.I. Cerebral venous pressure, gastric bypass surgery and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol 2006, 26:61-64.
168. Riggeal B.D., Bruce B.B., Saindane A.M., et al. Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 2013, 80(3):289-295.
169. Bono F., Quattrone A., Bruce B.B., et al. Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 2013, 81(7):695.
170. Huda-Baron R., Kupersmith M.J. Idiopathic intracranial hypertension in pregnancy. J Neurol 2002, 249(8):1078-1081.
171. Lee A.G., Pless M., Falardeau J., et al. The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. Am J Ophthalmol 2005, 139(5):855-859.
172. Shapiro S., Yee R., Brown H. Surgical management of pseudotumor cerebri in pregnancy: case report. Neurosurgery 1995, 37:829-831.
173. McDonnell G.V., Patterson V.H., McKinstry S. Cerebral venous thrombosis ocurring during an ectopic pregnancy and complicated by intracranial hypertension. Br J Clin Pract 1997, 51:194-197.
174. Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992, 37:155-166.
175. Cinciripini G.S., Donahue S., Borchert M.S. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment and outcome. Am J Ophthalmol 1999, 127:178-182.
176. Kesler A., Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol 2002, 17(10):745-748.
177. Dhiravibulya K., Ouvrier R., Johnston I., et al. Benign intracranial hypertension in childhood; a review of 23 patients. J Paediatr Child Health 1991, 27:204-207.
178. Baker R.S., Baumann R.J., Buncic J.R. Idiopathic intracranial hypertension (pseudotumor cerebri) in pediatric patients. Pediatr Neurol 1989, 5:5-11.
179. Baker R.S., Carter D.C., Hendrock E.B., et al. Visual loss in pseudotumor cerebri of childhood: a follow-up study. Arch Ophthalmol 1985, 103:1681-1686.
180. Phillips P.H., Repka M.X., Lambert S.R. Pseudotumor cerebri in children. J AAPOS 1998, 2(1):33-38.
181. Speer C., Pearlman J., Phillips P.H., et al. Fourth cranial nerve palsy in pediatric patients with pseudotumor cerebri. Am J Ophthalmol 1999, 127(2):236-237.
182. Schoeman J.F. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol 1994, 9:130-134.
183. Rangwala L.M., Liu G.T. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol 2007, 52(6):597-617.
184. Friedman D.I., Gordon L.K., Egan R.A., et al. Doxycycline and intracranial hypertension. Neurology 2004, 62:2297-2299.
185. Thambisetty M., Lavin P.J., Newman N.J., et al. Fulminant idiopathic intracranial hypertension. Neurology 2007, 68(3):229-232.
186. Ko M.W., Chang S.C., Ridha M.A., et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology 2011, 76(18):1564-1567.
187. Kikuchi M., Kudo S., Wada M., et al. Retropharyngeal rhabdomyosarcoma mimicking pseudotumor cerebri. Pediatr Neurol 1999, 21:496-499.
188. Molina J.C., Martinez-Vea A., Riu S., et al. Pseudotumor cerebri: an unusual complication of brachiocephalic vein thrombosis associated with hemodialysis catheters. Am J Kidney Dis 1998, 31:E3.
189. Kollar D.C., Johnston I.H. Pseudotumor after arteriovenous malformation embolisation. J Neurol Neurosurg Psychiatry 1999, 67:249-252.
190. Condulis N., Germain G., Charest N., et al. Pseudotumor cerebri: a presenting manifestation of Addison's disesae. Clin Pediatr 1997, 36:711-714.
191. Bourruat F.X., Regli F. Pseudotumor cerebri as a complication of amiodarone therapy. Am J Ophthalmol 1993, 116(6):776-777.
192. Fort J.A., Smith L.D. Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl. Ann Pharmacother 1999, 33:576-578.
193. Greer M. Benign intracranial hypertension. II. Following corticosteroid therapy. Neurology 1963, 13:439-441.
194. Walker A.E., Adamkiewitz J.J. Pseudotumor cerebri associated with prolonged corticosteroid therapy. JAMA 1964, 188(9):779-784.
195. Cruz O.A., Fogg S.G., Roper-Hall G. Pseudotumor cerebri associated with cyclosporine use. Am J Ophthalmol 1996, 122:436.
196. Blethen S.L. Complications of growth hormone therapy in children. Curr Opin Pediatr 1995, 7:466-471.
197. Grancois I., Castells I., Silberstein J., et al. Empty sella, growth hormone deficiency and pseudotumour cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy. Eur J Pediatr 1997, 156:69-70.
198. Koller E.A., Stadel B.V., Malozowski S.N. Papilledema in 15 renally compromised patients treated with growth hormone. Pediatr Nephrol 1997, 11:451-454.
199. Malozozwski S., Tanner L.A., Wysowski D.K., et al. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr 1995, 126:996-999.
200. Rogers A.H., Rogers G.L., Bremer D.L., et al. Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology 1999, 106:1186-1190.
201. Boot J.H. Pseudotumor cerebri as a side effect of leuprorelin acetate. Ir J Med Sci 1996, 165:60.
202. Campos S.P., Olitsky S. Idiopathic intracranial hypertension after L-thyroxine therapy for acquired hypothyroidism. Clin Pediatr 1995, 34:334-337.
203. Raghavan S., DiMartino-Nardi J., Saenger P., et al. Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism. J Pediatr 1997, 130:478-480.
204. Saul R.F., Hamburger H.A., Selhorst J.B. Pseudotumor cerebri secondary to lithium carbonate. JAMA 1985, 253:2869-2870.
205. Cohen D.N. Intracranial hypertension and papilledema associated with nalidixic acid therapy. Am J Ophthalmol 1973, 76:680-682.
206. Mukherjee A., Dutta B., Lahiri M., et al. Benign intracranial hypertension after nalidixic acid overdose in infants. Lancet 1990, 335:1602.
207. Wysowski D.K., Green L. Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch spontaneous reporting system. Obstet Gynecol 1995, 85:538-542.
208. Alder J., Fraunfelder F., Edwards R., et al. Levonorgestrel implants and intracranial hypertension. N Engl J Med 1995, 332(25):1720-1721.
209. Gardner K., Cox T., Digre K. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case report and review. Neurology 1995, 45:6-10.
210. Giles C.L., Soble A.R. Intracranial hypertension and tetracycline therapy. Am J Ophthalmol 1971, 72:981-982.
211. Lee A.G. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 1995, 55:165-168.
212. Meacock D.J., Hewer R.L. Tetracycline and benign intracranial hypertension. Br Med J 1981, 282:1240.
213. Minutello J.S., Dimayuga R.G., Carter J. Pseudotumor cerebri, a rare adverse reaction to tetracycline therapy. J Periodontol 1988, 58:848-851.
214. Maroon J.C., Mealy J. Benign intracranial hypertension. Sequel to tetracycline therapy in a child. JAMA 1971, 216(9):1479-1480.
215. Quinn A.G., Singer S.B., Bunic J.R. Pediatric tetracycline-induced pseudotumor cerebri. J AAPOS 1999, 3(1):53-57.
216. Ohlrich G.D., Ohlrich J.G. Papilloedema in an adolescent due to tetracycline. Med J Aust 1977, 1:334-335.
217. Pierog S.H., Al-Salihi F.L., Cinotti D. Pseudotumor cerebri - a complication of tetracycline treatment of acne. J Adolesc Health Care 1986, 7:139-140.
218. Stuart B.H., Litt I.F. Tetracycline-induced intracranial hypertension in an adolescent: a complication of systemic acne therapy. J Pediatr 1978, 92(4):679-680.
219. Chiu A.M., Chuenkongkaew W.L., Cornblath W.T., et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998, 126:116-121.
220. Moskowitz T., Leibowitz E., Ronen M., et al. Pseudotumor cerebri induced by vitamin A combined with minocycline. Ann Ophthalmol 1993, 25:306-308.
221. Donnet A., Dufour H., Graziani N., et al. Minocycline and benign intracranial hypertension. Biomed Pharmacother 1992, 46:171-172.
222. Beran R.G. Pseudotumor cerebri associated with minocycline therapy for acne. Med J Aust 1980, 1:323-324.
223. Lochhead J., Elston J.S. Doxycycline induced intracranial hypertension. BMJ 2003, 326:641-642.
224. Alemeyehu W. Pseudotumor cerebri (toxic effect of the "magic bullet"). Ethiop Med 1995, 33:265-270.
225. Feldman M.H., Schlezinger N.S. Benign intracranial hypertension associated with hypervitaminosis A. Arch Neurol 1970, 22:1-7.
226. Lombaert A., Carton H. Benign intracranial hypertension due to A-hypervitaminosis in adults and adolescents. Eur Neurol 1976, 14:340-350.
227. Fraunfelder F.W., Fraunfelder F.T., Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol 2001, 132(2):299-305.
228. Bigby M., Stern R.S. Adverse reactions to isotretinoin. A report for the Adverse Reaction Reporting System. J Am Acad Dermatol 1988, 18:543-552.
229. Roytman M., Frumkin A., Boyn T.G. Pseudotumor cerebri caused by isotretinoin. Cutis 1988, 42:399-400.
230. Lebowitz M.A., Berson D.S. Ocular effects of oral retinoids. J Am Acad Dermatol 1988, 19:209-211.
231. Fraunfelder F.W., Fraunfelder F.T., Corbett J.J. Isotretinoin usage and intracranial hypertension. Ophthalmology 2004, 111:1248-1250.
232. Tallman M.S., Andersen J.W., Schiffer C.A., et al. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 2000, 95(1):90-95.
233. Viraben R., Mathieu C., Fontan B. Benign intracranial hypertension during etretinate therapy for mycosis fungoides. J Am Acad Dermatol 1985, 13(3):515-517.
234. Bonnetblanc J.M., Hugon J., Dumas M., et al. Intracranial hypertension with etretinate. Lancet 1983, 2(8356):974.
235. Visani G., Manfroi S., Tosi P., et al. All-trans-retinoic acid and pseudotumor cerebri. Leuk Lymphoma 1996, 23:437-442.
236. Javeed N., Shaikh J., Jayaram S. Recurrent pseudotumor cerebri in an HIV-positive patient. AIDS 1995, 9:817-819.
237. Prevett M.C., Plant G.T. Intracranial hypertension and HIV associated meningoradiculitis. J Neurol Neurosurg Psychiatry 1997, 62:407-409.
238. Schwartz S., Husstedt I.W., Georgiadis D., et al. Benign intracranial hypertension in an HIV-infected patient: headache as the only presenting sign. AIDS 1995, 9:657-658.
239. Kan L., Sood S.K., Maytal J. Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol 1998, 18:439-441.
240. Konrad D., Kuster H., Hunzinker U.A. Pseudotumor cerebri after varicella. Eur J Pediatr 1998, 157:904-906.
241. Lahat E., Leshem M., Barzilai A. Pseudotumor cerebri complicating varicella in a child. Acta Paediatr 1998, 87:1310-1311.
242. Sussman J., Leach M., Greaves M., et al. Potentially pro-thrombotic abnormalities of coagulation in benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1997, 62:229-233.
243. Kesler A., Ellis M.G., Reshef T., et al. Idiopathic intracranial hypertension and anticardiolipin antibodies. J Neurol Neurosurg Psychiatry 2000, 68:379-380.
244. Leker R.R., Steiner I. Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension. Arch Neurol 1998, 55:817-820.
245. Kalbian V.V., Challis M.T. Behcet's disease: report of twelve cases with three manifesting as papilledema. Am J Med 1970, 49:823-829.
246. Teh L.S., O'Connor G.M., O'Sullivan M.M., et al. Recurrent papilloedema and early onset optic atrophy in Behcet's syndrome. Ann Rheum Dis 1990, 49:410-411.
247. Graham E.M., Al-Akshar R., Sanders M.D., et al. Benign intracranial hypertension in Behcet's syndrome. J Neuroophthalmol 1980, 1(1):73-76.
248. Martinez-Lage J.F., Alamo L., Poza M. Raised intracranial pressure in minimal forms of cranial synostosis. Childs Nerv Syst 1999, 15:11-15.
249. Au Eong K.G., Hariharan S., Chua E.C., et al. Idiopathic intracranial hypertension, empty sella turcica and polycyctic ovary syndromes - a case report. Singapore Med J 1997, 38:129-130.
250. Pelton R.W., Lee A.G., Orengo-Nania S.D., et al. Bilateral optic disk edema caused by sarcoidosis mimicking pseudotumor cerebri. Am J Ophthalmol 1999, 127:229-230.
251. Wolin M.J., Brannon W.L., Kay M.D., et al. Disk edema in an overweight woman (clinical conference). Surv Ophthalmol 1995, 39:307-314.
252. Miller J.J., Thomas D., Lynn J.L., et al. Sleep disorders: a risk factor for pseudotumor cerebri (PTC). Invest Ophthalmol Vis Sci 2000, 41(4):S313.
253. Purvin V.A., Kawasaki A., Yee R.D. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol 2000, 118(12):1626-1630.
254. Green L., Vinker S., Amital H., et al. Pseudotumor cerebri in systemic lupus erythematosis. Semin Arthritis Rheum 1995, 25:103-108.
255. Horoshovski D., Amital H., Katz M., et al. Pseudotumor cerebri in SLE. Clin Rheumatol 1995, 14:708-710.
256. Sybert V.P., Bird T.D., Salk D.J. Pseudotumor cerebri and Turner syndrome. J Neurol Neurosurg Psychiatry 1985, 48:164-166.